BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1375670)

  • 1. [In-vivo enhancement of neutrophil function by administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in cyclophosphamide (CPA) treated mice].
    Yoshida M
    Nihon Hinyokika Gakkai Zasshi; 1992 Apr; 83(4):518-27. PubMed ID: 1375670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of recombinant human granulocyte colony-stimulating factor on superoxide production by neutrophil in cancer patients receiving chemotherapy].
    Yoshida M; Oshi M; Aso Y; Yanagisawa R; Kishi H; Ishida Y
    Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1262-8. PubMed ID: 7689123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of recombinant human granulocyte colony-stimulating factor administration on neutropenia induced by cyclophosphamide in normal mice.
    Misaki M; Ueyama Y; Tsukamoto G; Matsumura T
    Br J Cancer; 1998 Mar; 77(6):884-9. PubMed ID: 9528829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
    Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
    Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of serum granulocyte-colony stimulating factor (G-CSF) concentration and G-CSF receptor expression during G-CSF treatment of cyclophosphamide-treated mice.
    Matsuzaki G; Li XY; Ohyama Y; Nomoto K
    Int J Immunopharmacol; 1996; 18(6-7):363-9. PubMed ID: 9024937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of recombinant human granulocyte-colony stimulating factor on neutropenic mice infected with Candida albicans: acceleration of recovery from neutropenia and potentiation of anti-C. albicans resistance.
    Hamood M; Bluche PF; De Vroey C; Corazza F; Bujan W; Fondu P
    Mycoses; 1994; 37(3-4):93-9. PubMed ID: 7531290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo effects of recombinant human granulocyte colony-stimulating factor on normal neutrophil function and membrane effector molecule expression.
    Itoh Y; Kuratsuji T; Tsunawaki S; Aizawa S; Toyama K
    Int J Hematol; 1991 Dec; 54(6):463-9. PubMed ID: 1724390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on respiratory burst activity of neutrophils in patients with myelodysplastic syndromes.
    Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Furusawa S; Miura Y; Takaku F; Saito M
    Clin Exp Immunol; 1993 Feb; 91(2):308-13. PubMed ID: 7679062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological effects of recombinant human granulocyte colony-stimulating factor modified by polyethylene glycol on anticancer drug-induced neutropenia in mice.
    Ishikawa M; Okada Y; Satake-Ishikawa R; Kakitani M; Kawagishi M; Matsuki S; Kusaka M; Asano K
    Gen Pharmacol; 1994 May; 25(3):533-7. PubMed ID: 7523237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system.
    Nishimura Y; Mayumi H; Tomita Y; Eto M; Maeda T; Nomoto K
    J Immunol; 1991 Apr; 146(8):2639-47. PubMed ID: 1707914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant human granulocyte colony-stimulating factor on variations of morphologically identifiable bone marrow cells in myelosuppressed mice.
    Kabaya K; Kusaka M; Seki M
    In Vivo; 1994; 8(6):1033-9. PubMed ID: 7539636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic activity (leukopoietic effect) of recombinant human granulocyte colony-stimulating factor (rhG-CSF) after rectal administration in rabbits with leukopenia induced by cyclophosphamide.
    Watanabe Y; Kiriyama M; Oe J; Kikuchi R; Mizufune Y; Matsumoto M
    Biol Pharm Bull; 1996 Aug; 19(8):1064-7. PubMed ID: 8874817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in total blood leukocyte count following intranasal administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rabbits with cyclophosphamide-induced leukopenia.
    Watanabe Y; Kikuchi R; Kiriyama M; Nakagawa K; Oe J; Nomura H; Maruyama K; Matsumoto M
    Biol Pharm Bull; 1995 Aug; 18(8):1084-8. PubMed ID: 8535401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats.
    Nohynek GJ; Plard JP; Wells MY; Zerial A; Roquet F
    Cancer Chemother Pharmacol; 1997; 39(3):259-66. PubMed ID: 8996530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil kinetics shortly after initial administration of recombinant human granulocyte colony-stimulating factor: neutrophil alkaline phosphatase activity as an endogenous marker.
    Katoh M; Shirai T; Shikoshi K; Ishii M; Saito M; Kitagawa S
    Eur J Haematol; 1992 Jul; 49(1):19-24. PubMed ID: 1379938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of granulocyte colony-stimulating factor and cephem antibiotics against experimental infections in neutropenic mice induced by cyclophosphamide.
    Wakiyama H; Tsuru S; Hata N; Shinomiya M; Shinomiya N; Noritake M; Umezawa Y; Rokutanda M
    Clin Exp Immunol; 1993 May; 92(2):218-24. PubMed ID: 7683585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma.
    Ohsaka A; Kitagawa S; Sakamoto S; Miura Y; Takanashi N; Takaku F; Saito M
    Blood; 1989 Dec; 74(8):2743-8. PubMed ID: 2479431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of rhG-CSF on neutrophil functions and bone marrow parameters in diabetic rats.
    Cantürk Z; Cantürk NZ; Cetinarslan B; Erçin C; Dökmetaş S; Sencan M
    Endocr Res; 1999; 25(3-4):381-95. PubMed ID: 10596730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
    Kabaya K; Obuchi M; Watanabe M; Kusaka M; Seki M
    Oncol Res; 1995; 7(3-4):165-71. PubMed ID: 8555650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factor does not enhance phagocytosis or microbicidal activity of human mature polymorphonuclear neutrophils in vitro.
    Shimono N; Okada K; Takeda D; Eguchi K; Misumi H; Sawae Y; Niho Y
    Clin Diagn Lab Immunol; 1994 Sep; 1(5):556-62. PubMed ID: 8556501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.